<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs are small, non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> of endogenous origin </plain></SENT>
<SENT sid="1" pm="."><plain>They have been increasingly shown to have altered expressions in many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types </plain></SENT>
<SENT sid="2" pm="."><plain>The expression levels of miR-375 have not been comprehensively investigated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, total <z:chebi fb="40" ids="33697">RNA</z:chebi> was extracted from 95 pairs of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues and non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> adjacent tissues, as well as from three <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines (HT-29, HCT-116 and SW-620) </plain></SENT>
<SENT sid="4" pm="."><plain>After polyadenylation and reverse transcription, we determined the expression levels of miR-375 by real-time PCR and calculated the difference in expression using the 2-∆∆Ct method </plain></SENT>
<SENT sid="5" pm="."><plain>We assessed the correlation between the expression levels of miR-375 and clinicopathological characteristics of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>miR-375 expression was frequently downregulated in the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues compared to the non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> counterparts (p&lt;0.001; paired t-test) </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, a significantly low expression of miR-375 was also found in the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines (HT-29, p=0.002; HCT-116, p&lt;0.001; SW-620, p=0.004; paired t-test) </plain></SENT>
<SENT sid="8" pm="."><plain>However, there were no significant correlations between the low expression of miR-375 and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, histological grade, pT stage, pN stage and pTNM stage (<z:hpo ids='HP_0000001'>all</z:hpo> P&gt;0.05, non-parametric test; Mann-Whitney U test between two groups and Kruskal-Wallis H test for three or more groups) </plain></SENT>
<SENT sid="9" pm="."><plain>miR-375 may be involved in the <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> and may be a potential biomarker for <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
</text></document>